American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an unlikely boomtown.
The Wall Street Journal on MSN11d
Ozempic’s new frontier: The war on agingA Novo Nordisk production line in Denmark for Ozempic pens. This could suggest anti-inflammatory benefits, or show that ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...
Novo’s share price fell 8 per cent on Monday, having previously dived in December after a late-stage trial of CagriSema in ...
Novo Nordisk is rolling out a new national marketing campaign for its GLP-1 juggernaut, teaming up with celebrities and other patients to show what life looks like in their “Ozempic Eras.” ...
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback